LapSpace Medical’s inflatable laparoscopic retractor gives surgeons effective retraction of organs such as the intestines.
The market requires a simple, safe retraction technique.
LapSpace’s inflatable balloon retractor has proven itself in animal trials for better and more efficient retraction of organs such as the intestines.
How It Works
Deployed through a standard trocar and inflated inside the abdominal cavity, the retractor gently and effectively “catches” and retracts the organs to create a stable operating field. When the procedure is completed, the device is deflated and removed through the entry port.
The retractor’s self-retaining clamp allows it to remain in place for long periods of time, without the need for additional surgical personnel.
The LapSpace inflatable retractor greatly improves efficiency and decreases the cost of the surgery.
Founded: December 2011
Investor: The Trendlines Group
Laparoscopic procedures have become the new surgical standard in the last decade. The success of laparoscopic procedures, however, depends on optimal exposure of the operating site. Advantages include smaller incisions, quicker recovery, less scarring, lower infection rates, less post-surgical pain, and shorter hospital stays.
Currently, abdominal organs obstructing the view are inefficiently retracted from the target organ. This leads to an unstable field that does not create a large enough working space, increasing the risk of injury to surrounding tissue, and complication rates.
The current method of creating space includes tilting the entire operating room table at steep angles to allow some organs to “fall away.” If this does not work, then the delicate organs are pushed and pulled away with jagged-tooth graspers that require additional ports and personnel. These inefficient methods lead to inconsistent retraction and longer operating times as well as potential complications such as bowel perforation, bleeding, bruising, and falling.
According to research conducted by LapSpace, there are over 4 million laparoscopic procedures performed annually in the United States.
LapSpace estimates that 2 million of these procedures, or 50%, could benefit from its proprietary inflatable laparoscopic retractor.
See the company presentation (English PDF).
See the company one-page description in Chinese (PDF).
See the company presentation in Chinese (PDF).
Watch the LapSpace retractor used in live surgeries.
CEO Assaf Livne presents at a Trendlines Showcase.
Minimally invasive treatment of heart valve disease
A more efficient ablation catheter to treat atrial fibrillation
Preventing the development of pressure sores
Novel treatment for vertebral compression fractures
Preventing catheter-associated urinary tract infections (CAUTIs)
Wireless, wearable vital sign monitoring system
Cryotherapy for superficial bladder cancer